In GC, Tigecycline inhibits cell (GAM-016 and MKN-45) proliferation and is able to induce autophagy through the activation of the AMPK pathway and suppression of its downstream targets, such as mTOR and p70S6K. This evidence concerns the gene MTOR and gastric cancer.